Promoting Resilience in Adolescents and Young Adults with Sickle Cell Disease
This study is looking at ways to help adolescents and young adults (ages 8-25) with sickle cell disease (SCD) manage their illness and improve their well-being. It's testing a program called "Promoting Resilience in Stress Management" (PRISM) along with a "Collaborative Care Model." PRISM helps with stress management, setting goals, and positive thinking, and is delivered one-on-one by trained coaches. The Collaborative Care Model involves a team meeting weekly to review your needs and offer support. The main goal is to see if these approaches are practical and well-received by patients. Researchers will also explore if they can help reduce depression, anxiety, and pain. You may be able to join if you have SCD, receive care at DFCI/BCH, and have certain scores on anxiety or depression questionnaires. This study plans to enroll 25 participants, but its current status is unclear.
- Study design
- This is an interventional study that plans to enroll 25 participants. It is testing a behavioral intervention delivered through a collaborative care model.
- What's involved
- Sessions for the PRISM intervention are delivered every 1-2 weeks based on your preference. The interprofessional team will meet weekly to review survey scores and health needs.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary goal of the study is measured at 3 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Promoting Resilience Among Adolescents and Young Adults With Sickle Cell Disease
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Enrollment rate (feasibility)3-months
feasibility assessed by \>50% enrollment rate